| pubmed-article:19834106 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C1861172 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C0279025 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C0232970 | lld:lifeskim |
| pubmed-article:19834106 | lifeskim:mentions | umls-concept:C0332240 | lld:lifeskim |
| pubmed-article:19834106 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19834106 | pubmed:dateCreated | 2010-1-21 | lld:pubmed |
| pubmed-article:19834106 | pubmed:abstractText | Oral estrogen therapy increases venous thromboembolism risk among postmenopausal women. Although recent data showed transdermal estrogens may be safe with respect to thrombotic risk, the impact of the route of estrogen administration and concomitant progestogens is not fully established. | lld:pubmed |
| pubmed-article:19834106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19834106 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19834106 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19834106 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19834106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19834106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19834106 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19834106 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19834106 | pubmed:issn | 1524-4636 | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:Boutron-Ruaul... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:OgerEmmanuelE | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:ScarabinPierr... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:Clavel-Chapel... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:Plu-BureauGen... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:FournierAgnès... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:CanonicoMaria... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:MesrineSylvie... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:CarcaillonLau... | lld:pubmed |
| pubmed-article:19834106 | pubmed:author | pubmed-author:OliéValérieV | lld:pubmed |
| pubmed-article:19834106 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19834106 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:19834106 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19834106 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19834106 | pubmed:pagination | 340-5 | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:meshHeading | pubmed-meshheading:19834106... | lld:pubmed |
| pubmed-article:19834106 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19834106 | pubmed:articleTitle | Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. | lld:pubmed |
| pubmed-article:19834106 | pubmed:affiliation | Inserm Unit 780, Cardiovascular Epidemiology Section, Cedex, France. marianne.canonico@inserm.fr | lld:pubmed |
| pubmed-article:19834106 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19834106 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19834106 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19834106 | lld:pubmed |
